AACAP Work Group on Quality Issues, Birmaher, B, Brent, D, Bernet, W, Bukstein, O, Walter, H, Benson, RS, Chrisman, A, Farchione, T, Greenhill, L, Hamilton, J, Keable, H, Kinlan, J, Schoettle, U, Stock, S, Ptakowski, KK and Medicus, J (2007 a) Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry 46, 1503–1526.
AACAP Work Group on Quality Issues, McClellan, J, Kowatch, R and Findling, RL (2007 b) Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 46, 107–125.
AACAP Work Group on Quality Issues and Pliszka, S (2007 c). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 46, 894–921.
American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI), McClellan, J and Stock, S (2013) Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry 52, 976–990.
Antshel, KM, Fremont, W, Roizen, NJ, Shprintzen, R, Higgins, AM, Dhamoon, A and Kates, WR (2006) ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 45, 596–603.
Antshel, KM, Faraone, SV, Fremont, W, Monuteaux, MC, Kates, WR, Doyle, A, Mick, E and Biederman, J (2007) Comparing ADHD in velocardiofacial syndrome to idiopathic ADHD: a preliminary study. Journal of Attention Disorders 11, 64–73.
Antshel, KM, Shprintzen, R, Fremont, W, Higgins, AM, Faraone, SV and Kates, WR (2010) Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 49, 333–344.
Antshel, KM, Hendricks, K, Shprintzen, R, Fremont, W, Higgins, AM, Faraone, SV and Kates, WR (2013) The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome. The Journal of Pediatrics 163, 187–193, e1.
Asselmann, E and Beesdo-Baum, K (2015) Predictors of the course of anxiety disorders in adolescents and young adults. Current Psychiatry Reports 17, 7.
Bassett, AS and Chow, EW (2008) Schizophrenia and 22q11. 2 deletion syndrome. Current Psychiatry Reports 10, 148.
Biederman, J, Petty, CR, Clarke, A, Lomedico, A and Faraone, SV (2011) Predictors of persistent ADHD: an 11-year follow-up study. Journal of Psychiatric Research 45, 150–155.
Biederman, J, Petty, CR, O'Connor, KB, Hyder, LL and Faraone, SV (2012) Predictors of persistence in girls with attention deficit hyperactivity disorder: results from an 11-year controlled follow-up study. Acta Psychiatrica Scandinavica 125, 147–156.
Boot, E, Butcher, N, Vorstman, J, van Amelsvoort, T, Fung, W and Bassett, A (2015) Pharmacological treatment of 22q11.2 deletion syndrome-related psychoses. Pharmacopsychiatry 25, 219–220.
Botto, LD, May, K, Fernhoff, PM, Correa, A, Coleman, K, Rasmussen, SA, Merritt, RK, O'Leary, LA, Wong, LY, Elixson, EM, Mahle, WT and Campbell, RM (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112, 101–107.
Bruce, SE, Yonkers, KA, Otto, MW, Eisen, JL, Weisberg, RB, Pagano, M, Shea, MT and Keller, MB (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. American Journal of Psychiatry 162, 1179–1187.
Butcher, NJ, Fung, WL, Fitzpatrick, L, Guna, A, Andrade, DM, Lang, AE, Chow, EW and Bassett, AS (2015) Response to clozapine in a clinically identifiable subtype of schizophrenia. The British Journal of Psychiatry: the Journal of Mental Science 206, 484–491.
Cherkasova, M, Sulla, EM, Dalena, KL, Ponde, MP and Hechtman, L (2013) Developmental course of attention deficit hyperactivity disorder and its predictors. Journal of the Canadian Academy of Child and Adolescent Psychiatry 22, 47–54.
Copeland, WE, Shanahan, L, Costello, EJ and Angold, A (2009) Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Archives of General Psychiatry 66, 764–772.
Copeland, WE, Angold, A, Shanahan, L and Costello, EJ (2014) Longitudinal patterns of anxiety from childhood to adulthood: the great smoky mountains study. Journal of the American Academy of Child and Adolescent Psychiatry 53, 21–33.
Dekker, MC and Koot, HM (2003) DSM-IV disorders in children with borderline to moderate intellectual disability. I. Prevalence and impact. Journal of the American Academy of Child & Adolescent Psychiatry 42, 915–922.
Dori, N, Green, T, Weizman, A and Gothelf, D (2017) The effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q11.2 deletion syndrome. Journal of Child and Adolescent Psychopharmacology 27, 83–90.
Dunn, V and Goodyer, IM (2006) Longitudinal investigation into childhood- and adolescence-onset depression: psychiatric outcome in early adulthood. The British Journal of Psychiatry: the Journal of Mental Science 188, 216–222.
Faraone, SV, Sergeant, J, Gillberg, C and Biederman, J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2, 104–113.
Faraone, SV, Biederman, J and Mick, E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 36, 159–165.
Gothelf, D, Feinstein, C, Thompson, T, Gu, E, Penniman, L, Van Stone, E, Kwon, H, Eliez, S and Reiss, AL (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. American Journal of Psychiatry 164, 663–669.
Gothelf, D, Schneider, M, Green, T, Debbane, M, Frisch, A, Glaser, B, Zilkha, H, Schaer, M, Weizman, A and Eliez, S (2013) Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. Journal of the American Academy of Child and Adolescent Psychiatry 52, 1192–1203, e3.
Grati, FR, Molina Gomes, D, Ferreira, JC, Pinto, B, Dupont, C, Alesi, V, Gouas, L, Horelli-Kuitunen, N, Choy, KW, García-Herrero, S and Vega, AG (2015) Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenatal Diagnosis 35, 801–809.
Green, T, Gothelf, D, Glaser, B, Debbane, M, Frisch, A, Kotler, M, Weizman, A and Eliez, S (2009) Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1060–1068.
Green, T, Weinberger, R, Diamond, A, Berant, M, Hirschfeld, L, Frisch, A, Zarchi, O, Weizman, A and Gothelf, D (2011) The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome. Journal of Child and Adolescent Psychopharmacology 21, 589–595.
Grover, RL, Ginsburg, GS and Ialongo, N (2005) Childhood predictors of anxiety symptoms: a longitudinal study. Child Psychiatry and Human Development 36, 133–153.
Hollingshead, AB (1975). Four factor index of social status. Unpublished Manuscript. Yale University: New Haven, CT.
Kates, W, Russo, N, Wood, W, Antshel, K, Faraone, S and Fremont, W (2015) Neurocognitive and familial moderators of psychiatric risk in velocardiofacial (22q11.2 deletion) syndrome: a longitudinal study. Psychological Medicine 45, 1629–1639.
Kessler, RC, McGonagle, KA, Zhao, S, Nelson, CB, Hughes, M, Eshleman, S, Wittchen, H and Kendler, KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Archives of General Psychiatry 51, 8–19.
Kessler, RC, Avenevoli, S and Merikangas, KR (2001) Mood disorders in children and adolescents: an epidemiologic perspective. Biological Psychiatry 49, 1002–1014.
Knappe, S, Beesdo, K, Fehm, L, Höfler, M, Lieb, R and Wittchen, H (2009) Do parental psychopathology and unfavorable family environment predict the persistence of social phobia? Journal of Anxiety Disorders 23, 986–994.
Legerstee, JS, Verhulst, FC, Robbers, SC, Ormel, J, Oldehinkel, AJ and van Oort, FV (2013) Gender-specific developmental trajectories of anxiety during adolescence: determinants and outcomes. The TRAILS study. Journal of the Canadian Academy of Child and Adolescent Psychiatry 22, 26–34.
Lord, C, Rutter, M and Le Couteur, A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders 24, 695–685.
Mariano, MA, Tang, K, Kurtz, M and Kates, WR (2015) Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention. Schizophrenia Research 166, 283–289.
Mariano, MA, Tang, K, Kurtz, M and Kates, WR (2018) Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome. Early Intervention in Psychiatry 12, 686–693.
Maughan, B (2013) Counting the cost: estimating the burden of child mental health. Journal of Child Psychology and Psychiatry 54, 1261–1262.
Merikangas, KR, He, JP, Burstein, M, Swanson, SA, Avenevoli, S, Cui, L, Benjet, C, Georgiades, K and Swendsen, J (2010) Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication – Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 49, 980–989.
Merikangas, KR, He, J, Rapoport, J, Vitiello, B and Olfson, M (2013) Medication use in US youth with mental disorders. JAMA Pediatrics 167, 141–148.
Murphy, KC, Jones, LA and Owen, MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry 56, 940–945.
Platt, JM, Keyes, KM, McLaughlin, KA and Kaufman, AS (2018) Intellectual disability and mental disorders in a US population representative sample of adolescents. Psychological Medicine 12, 1–10. doi: https://doi.org/10.1017/S0033291718001605.
Reynolds, CR and Kamphaus, RW (1992) Behavior Assessment Scales for Children (BASC). Circle Pines, MN: American Guidance Service.
Rubin, D (2013) Conflicting data on psychotropic use by children: two pieces to the same puzzle. JAMA Pediatrics 167, 189–190.
Schneider, M, Debbané, M, Bassett, AS, Chow, EW, Fung, WLA, Van Den Bree, Van Den Bree MBM, , Owen, M, Murphy, KC, Niarchou, M and Kates, WR (2014) Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. American Journal of Psychiatry 171, 627–639.
Seguin, JR and Leckman, JF (2013) Developmental approaches to child psychopathology: longitudinal studies and implications for clinical practice. Journal of the Canadian Academy of Child and Adolescent Psychiatry 22, 3–5.
Shaffer, D, Gould, MS, Brasic, J, Ambrosini, P, Fisher, P, Bird, H and Aluwahlia, S (1983) A children's global assessment scale (CGAS). Archives of General Psychiatry 40, 1228–1231.
Skodol, AE, Geier, T, Grant, BF and Hasin, DS (2014) Personality disorders and the persistence of anxiety disorders in a nationally representative sample. Depression and Anxiety 31, 721–728.
Stoddard, J, Niendam, T, Hendren, R, Carter, C and Simon, TJ (2010) Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophrenia Research 118, 118–121.
Tang, S, Yi, J, Calkins, M, Whinna, D, Kohler, C, Souders, M, McDonald-McGinn, D, Zackai, E, Emanuel, B and Gur, R (2014) Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychological Medicine 44, 1267–1277.
Tang, SX, Moore, TM, Calkins, ME, Yi, JJ, Savitt, A, Kohler, CG, Souders, MC, Zackai, EH, McDonald-McGinn, DM, Emanuel, BS, Gur, RC and Gur, RE (2017) The psychosis spectrum in 22q11.2 deletion syndrome is comparable to that of nondeleted youths. Biological Psychiatry 82, 17–25.
Taylor, LE, Kates, WR, Fremont, W and Antshel, KM (2018) Young adult outcomes for children with 22q11 deletion syndrome and comorbid ADHD. Journal of Pediatric Psychology 43, 636–644.
Vorstman, JA, Breetvelt, EJ, Duijff, SN, Eliez, S, Schneider, M, Jalbrzikowski, M, Armando, M, Vicari, S, Shashi, V, Hooper, SR, Chow, EW, Fung, WL, Butcher, NJ, Young, DA, McDonald-McGinn, DM, Vogels, A, van Amelsvoort, T, Gothelf, D, Weinberger, R, Weizman, A, Klaassen, PW, Koops, S, Kates, WR, Antshel, KM, Simon, TJ, Ousley, OY, Swillen, A, Gur, RE, Bearden, CE, Kahn, RS, Bassett, AS; International Consortium on, Brain and Behavior, in 22q11.2 Deletion, Syndrome (2015) Cognitive decline preceding the onset of psychosis in patients with 22q11. 2 deletion syndrome. JAMA psychiatry, 72, 377–385.
Wechsler, D (1997) Wechsler Adult Intelligence Scale, 3rd Edn. San Antonio, TX: Psychological Corporation.
Weinberger, R, Weisman, O, Guri, Y, Harel, T, Weizman, A and Gothelf, D (2018) The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: a longitudinal comparative study. European psychiatry: the journal of the Association of European Psychiatrists 48, 20–26.
Yi, JJ, Calkins, ME, Tang, SX, Kohler, CG, McDonald-McGinn, DM, Zackai, EH, Savitt, AP, Bilker, WB, Whinna, DA, Souders, MC, Emanuel, BS, Gur, RC and Gur, RE (2015) Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome. The Journal of Clinical Psychiatry 76, e1262–e1270.